Literature DB >> 24067294

Clinical features and management of organic acidemias in Japan.

Daisuke Fujisawa1, Kimitoshi Nakamura1, Hiroshi Mitsubuchi1, Toshihiro Ohura2, Yosuke Shigematsu3, Tohru Yorifuji4, Mureo Kasahara5, Reiko Horikawa6, Fumio Endo1.   

Abstract

Organic acidemias (OAs) are rare inborn errors of metabolism. The clinical presentations of methylmalonic acidemia (MMA) and propionic acidemia (PA) in Japan have not yet been examined in detail. We aimed to investigate the clinical presentations of OAs in Japan and evaluate current therapies for improving long-term outcomes, especially in MMA and PA cases. Questionnaires were sent to 928 institutions in 2009 inquiring about OAs, and secondary questionnaires were sent to those who confirmed that they had diagnosed and/or treated such cases; 119 cases were eventually included for analysis. In Japan, the majority of OAs was MMA, which was associated with a high mortality rate. The survival rates at 20 years of age in vitamin B12-unresponsive MMA, vitamin B12-responsive MMA and PA patients were 69.8%, 94.4% and 95.8%, respectively. Factors associated with mortality in MMA were failure to thrive, hypoglycemia and pancreatitis. Factors associated with mental retardation in vitamin B12-unresponsive MMA, vitamin B12-responsive MMA, and PA were seizure and liver dysfunction, seizure and failure to thrive, and failure to thrive, respectively. We advocated that avoiding failure to thrive due to too restricted protein diet, hypoglycemia and pancreatitis associated with mortality lead to improve outcome, especially in vitamin B12-unresponsive MMA patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067294     DOI: 10.1038/jhg.2013.97

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  5 in total

1.  Successful Domino Liver Transplantation from a Patient with Methylmalonic Acidemia.

Authors:  A Khanna; R Gish; S C Winter; W L Nyhan; B A Barshop
Journal:  JIMD Rep       Date:  2015-07-29

2.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

Review 3.  The Value of Liver Transplantation for Methylmalonic Acidemia.

Authors:  Yi-Zhou Jiang; Li-Ying Sun
Journal:  Front Pediatr       Date:  2019-03-21       Impact factor: 3.418

4.  Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report.

Authors:  Yi-Zhou Jiang; Yu Shi; Ying Shi; Lan-Xia Gan; Yuan-Yuan Kong; Zhi-Jun Zhu; Hai-Bo Wang; Li-Ying Sun
Journal:  Orphanet J Rare Dis       Date:  2019-12-16       Impact factor: 4.123

5.  Therapeutic potential of living donor liver transplantation from heterozygous carrier donors in children with propionic acidemia.

Authors:  Zhi-Gui Zeng; Guang-Peng Zhou; Lin Wei; Wei Qu; Ying Liu; Yu-Le Tan; Jun Wang; Li-Ying Sun; Zhi-Jun Zhu
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.